CytoDyn, Inc. (OTC: CYDY) is at the forefront of COVID-19 and NASH research with its Leronlimab therapy. CEO Dr. Pourhassan discusses the drug's potential on Fox Business, highlighting its progress in clinical trials. Stay tuned for updates on CytoDyn's innovative efforts in the battle against these debilitating diseases.